BSE: GRANULES - Granules India Limited

六个月盈利: +12.76%

促销时间表 Granules India Limited

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology.

更多详情
Granules India Limited was founded in 1984 and is based in Hyderabad, India.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

ISIN INE101D01020
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.4754
Дивиденд ао 1.5
Сайт https://www.granulesindia.com
Цена ао 567.5
每日价格变化: +3.47% (567.5)
每周价格变化: -4.79% (616.75)
每月价格变化: +0.3075% (585.4)
3个月内价格变化: -2.1% (599.8)
六个月内的价格变化: +12.76% (520.75)
每年价格变化: +36.53% (430.1)
3年内价格变化: +80.79% (324.8)
5年内价格变化: +374.89% (123.65)
10年价格变化: 0% (587.2)
年初以来价格变化: -0.4239% (589.7)
所有参数

低估

姓名 意义 年级
P/S 2.08 7
P/BV 2.9 6
P/E 23.09 6
EV/EBITDA 9.42 8
全部的: 6.13

效率

姓名 意义 年级
ROA, % 7.34 2
ROE, % 12.57 4
全部的: 2.67

股息

姓名 意义 年级
Div yield, % 0.4754 1.2
DSI 0.9286 9.29
全部的: 3.4

责任

姓名 意义 年级
Debt/EBITDA 1.32 8
全部的: 8.2

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 72.79 8
盈利能力 Ebitda, % 52.2 7
盈利能力 EPS, % 38.73 5
全部的: 4.8
更多详情

ETF 分享, % 本年盈利能力, % 股息, %
iShares MSCI India Small-Cap ETF 0.2039 0.4625 0.96163
SPDR S&P Emerging Markets Small Cap ETF 0.08617 5.46 3.03583
WisdomTree India Earnings Fund 0.07585 5.23 1.65591
Dimensional Emerging Markets Value ETF 0.07511 17.07 4.19508
iShares MSCI Emerging Markets Small-Cap ETF 0.07375 7.67 2.7853
Avantis Emerging Markets Value ETF 0.04379 14.12 4.22231
SPDR Portfolio Emerging Markets ETF 0.04218 11.59 3.1879
Vanguard FTSE All-World ex-US Small-Cap ETF 0.04 9.39 3.09932
Dimensional Emerging Markets Core Equity 2 ETF 0.03849 15.96 3.34087
Avantis Emerging Markets Equity ETF 0.03261 8.77 3.60513
Dimensional World ex U.S. Core Equity 2 ETF 0.01559 13.06 3.62488
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.01338 12.46 3.59676
SPDR Portfolio MSCI Global Stock Market ETF 0.01101 17.99 2.19607
iShares Core MSCI Total International Stock ETF 0.00514 6.4 3.25258
Vanguard ESG International Stock ETF 0 6.39 3.07501

导师 职称 支付 出生年份
Dr. Krishna Prasad Chigurupati B.Sc. Chairman & MD 353.56M 1954 (71 年)
Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D. Joint MD, CEO & Additional Director 94.56M 1963 (62 年)
Ms. Chaitanya Tummala Company Secretary & Compliance Officer 7.89M
Mr. Mukesh Surana Chief Financial Officer N/A 1981 (44 年)
Dr. P. V. Srinivas Chief Technology Officer N/A 1966 (59 年)
Mr. Sanjay Kumar President and Chief Strategy & Sustainability Officer N/A
Mr. Atul Dhavle B.E. Chief Human Resources Officer N/A 1970 (55 年)
Mr. Harsha Chigurupati BBA Executive Director 1983 (42 年)
Mr. Sethu Madhavan Sankaran Senior Vice President of API Manufacturing & Operations
Ms. Priyanka Chigurupati Whole-Time Director

地址: India, Hyderabad, My Home Hub - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.granulesindia.com